Tolerance associated gene expression following allogeneic hematopoietic cell transplantation.
Biologic markers of immune tolerance may facilitate tailoring of immune suppression duration after allogeneic hematopoietic cell transplantation (HCT). In a cross-sectional study, peripheral blood samples were obtained from tolerant (n = 15, median 38.5 months post-HCT) and non-tolerant (n = 17, med...
Main Authors: | Joseph Pidala, Gregory C Bloom, Steven Eschrich, Minnie Sarwal, Steve Enkemann, Brian C Betts, Francisca Beato, Sean Yoder, Claudio Anasetti |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4361657?pdf=render |
Similar Items
-
Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia
by: Nishihori Taiga, et al.
Published: (2010-10-01) -
Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation
Published: (2020) -
Association of Patient-Reported Physical Activity on Allogeneic Hematopoietic Cell Transplant Outcomes
by: Reena V. Jayani, et al.
Published: (2021-03-01) -
Editorial: Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation
by: Dominik Schneidawind, et al.
Published: (2020-03-01) -
ROLE AND TIMING OF HEMATOPOIETIC CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME
by: Teresa L Field, et al.
Published: (2010-07-01)